Zynex, Inc. (NASDAQ:ZYXI – Get Rating) – Investment analysts at B. Riley lowered their Q2 2022 earnings estimates for Zynex in a research note issued on Friday, July 15th. B. Riley analyst M. Wiesenberger now forecasts that the company will post earnings per share of $0.07 for the quarter, down from their prior estimate of […]
Wall Street brokerages predict that Zynex, Inc. (NASDAQ:ZYXI – Get Rating) will report $36.42 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have made estimates for Zynex’s earnings, with the highest sales estimate coming in at $36.76 million and the lowest estimate coming in at $36.00 million. Zynex […]
Zynex (NASDAQ:ZYXI – Get Rating) and Natus Medical (NASDAQ:NTUS – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Insider & Institutional Ownership 28.1% of Zynex shares are held […]
Shares of Zynex, Inc. (NASDAQ:ZYXI – Get Rating) have been assigned an average rating of “Buy” from the six analysts that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation and three have issued a buy recommendation on the company. The average 12 month price […]
Zynex (NASDAQ:ZYXI – Get Rating) and Natus Medical (NASDAQ:NTUS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation. Earnings and Valuation This table compares Zynex and Natus Medical’s […]